GlassScriptPhysician profile
Rachel E Kinney
NPI 1376953174
$1,343.71
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $69.84 · 2021: $165 · 2022: $331 · 2023: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $299 · Food and Beverage: $18.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $299.10 |
| Food and Beverage | $18.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $652.08 | 2019-2023 | |
| Incyte Corporation | $217.95 | 2019-2022 | |
| Seagen INC. | $121.31 | 2019-2021 | |
| Clovis Oncology, INC. | $99.95 | 2019 | |
| Janssen Biotech, INC. | $81.72 | 2019-2021 | |
| Amgen INC. | $74.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.09 | 2022 | |
| Abbvie INC. | $19.84 | 2020 | |
| Astellas Pharma US INC | $19.79 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $18.08 | 2023 | Imbruvica |
| Foundation Medicine, INC. | $17.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Kinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.